advertisement

WGA Rescources

Russo R 12

Showing records 1 to 12 | Display all abstracts from Russo R

67178 Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation
Russo R
European Journal of Pharmacology 2016; 787: 134-142
67540 New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
Nucci C
European Journal of Pharmacology 2016; 787: 119-126
67178 Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation
Varano GP
European Journal of Pharmacology 2016; 787: 134-142
67540 New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
Russo R
European Journal of Pharmacology 2016; 787: 119-126
67178 Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation
Adornetto A
European Journal of Pharmacology 2016; 787: 134-142
67540 New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
Martucci A; Giannini C
European Journal of Pharmacology 2016; 787: 119-126
67178 Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation
Nucci C
European Journal of Pharmacology 2016; 787: 134-142
67540 New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
Garaci F
European Journal of Pharmacology 2016; 787: 119-126
67178 Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation
Corasaniti MT; Bagetta G
European Journal of Pharmacology 2016; 787: 134-142
67540 New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
Floris R; Bagetta G
European Journal of Pharmacology 2016; 787: 119-126
67178 Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation
Morrone LA
European Journal of Pharmacology 2016; 787: 134-142
67540 New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
Morrone LA
European Journal of Pharmacology 2016; 787: 119-126

Issue 17-4

Change Issue


advertisement

Oculus